# Tvardi Therapeutics, Inc.: Form 8-K/A, filed Dec 20, 2024

- Company: [Tvardi Therapeutics, Inc.](/companies/tvrd.md) (CIK 1346830)
- Form: 8-K/A
- Filed: 2024-12-20
- Accepted by EDGAR: Dec 20, 2024, 16:05 ET
- Period: 2024-12-17
- Accession: 0001104659-24-130803
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1346830/000110465924130803/tm2431662d1_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1346830/000110465924130803/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1346830/000110465924130803/tm2431662d1_8ka.htm

Filed Dec 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-130803. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.